Dr. Alexander “Sandro” Sulakvelidze, Ph.D., is the President and CEO of Intralytix, Inc. He is an internationally recognized expert in phage technology, with over 25 years of experience working in the bacteriophage field, from candidate phage product development to regulatory approvals and subsequent commercialization. Dr. Sulakvelidze co-founded Intralytix in 1998, and he has been serving in different senior management positions in the Company since inception, until becoming President and CEO of Intralytix in 2020. Dr. Sulakvelidze earned his B.S. in Biology from Tbilisi State University and his Ph.D. from Tbilisi Medical University, both in Tbilisi, Georgia. He has completed his post-doctoral training at the University of Maryland Medical School in Baltimore Maryland.
Mel Ruzicka is the Chief Financial Officer of Intralytix, Inc. For over 40 years, Mr. Ruzicka has served as CFO in industries such as Insurance, Manufacturing, Healthcare, Banking and Transportation. Mr. Ruzicka specializes in managing the growth and expansion of small companies during their growth stage. Mr. Ruzicka has been the CFO of Intralytix since 2007. He is responsible for all Accounting, Audit, Human Resources, and Strategic Planning and Budgeting. He also serves as Corporate Secretary to the Board of Directors. Mr. Ruzicka earned an MBA from Loyola University, Maryland.
Joelle Woolston is the Vice President of Lab Operations at Intralytix, Inc. Joelle has been with the company for over 15 years, initially serving as a hands-on researcher, contributing to the development and optimization of several phage cocktails. She now directs and supervises the R&D and QC laboratory staff and their current research and development projects. Ms. Woolston earned her B.S. in Biology from Nazareth College in Rochester, NY, and her M.S. in Agronomy from University of Maryland in College Park, MD.
Scott Gibbons is the Director of Manufacturing at Intralytix, Inc. Scott brings over 20 years of cross-functional biotechnology experience to the Company. He has spent over a decade working specifically in the bacteriophage field, with a focus primarily on Process Development and Manufacturing. Prior to Intralytix, Scott worked as Director of Microbial Process Development at Paragon Bioservices (now Catalent Inc.), focusing not only on bacteriophage, but also vaccines and therapeutic proteins.
Scott obtained his B.S. from St. Mary’s College of Maryland, and an M.S. in Cellular and Molecular Biology from Towson University.
When not working, Scott is an avid fisherman who can often be found out in the ocean chasing after gamefish or enjoying a local microbrew with his rescue dog.
Dr. Jennifer Schwartz, Ph.D. is the Vice President of Clinical Development at Intralytix, Inc. Her primary expertise is in virology, vaccine/drug design and development, and IND-enabling preclinical and clinical development of biologics targeting infectious diseases. She received her B.S. with honors in Biological Sciences from Carnegie Mellon University. Dr. Schwartz earned her M.A., M.Phil. and Ph.D. from Columbia University in Cellular, Molecular and Biophysical Studies at the College of Physicians and Surgeons and performed her post-doctoral training at Yale University School of Medicine.
Greg Strang serves as the Director of the Food Safety Division of Intralytix Inc. In that position, Greg is responsible for leading the sales and business development efforts in the food processing sector at Intralytix. Greg received his bachelor’s and master’s degrees from Indiana University. He began his career with Ross Laboratories in their nutrition science division. He then became the managing director of a division of the DuPont Corporation. Over his 16-year tenure with DuPont, Greg held various positions, all specializing in the food processing industry and in 2003 he was awarded the coveted DuPont Marketing Excellence Award. After joining Intralytix, Greg was directly responsible for increasing food safety product sales by more than 800% during 2015-2022.
Hal Warso is the Director of Quality Assurance at Intralytix, Inc. He received his undergraduate degree in Chemical Engineering and Management from Clarkson University. Prior to joining Intralytix in 2019, Hal was responsible for designing, implementing, and maintaining Quality Management Systems in the Contract Laboratory Industry and Nutraceutical Industry. He is certified as a Food Safety Preventative Controls Alliance Qualified Individual for both the Preventative Controls for Human Food Program and Foreign Supplier Verification Programs. Hal also holds certifications for SQF Quality Systems Implementation and SQF Manufacturing Systems Implementation.
Bradley Anderson is the Vice President of Production and Logistics at Intralytix, Inc. Bradley has been with Intralytix, Inc. for over 15 years where he has responsibility to manage Intralytix bacteriophage manufacturing operations. He has designed and implemented custom software as critical infrastructure enabling insightful analytics, product quality control, new process development, inventory management, and systems integration. Mr. Anderson earned his B.S.E. in Chemical Engineering from the University of Michigan in 2007.